“GLP-1 drugs don’t just change what people eat,” Karthik Srinivasan, communications strategy consultant, tells Invezz.They change whether people want to eat at all. That’s why this stops being a marketing problem and becomes a business-model problem for a whole lot of categories.The weight-loss drug boom didn’t just spark a health…
The Trump administration on Thursday unveiled what it called the “Great Healthcare Plan,” a broad framework aimed at addressing…
Morgan Stanley capped an exceptional 2025 with a fourth-quarter earnings beat that showcased the power of its diversified business…
Initial claims for unemployment benefits in the United States fell more than expected in early January, offering fresh evidence…
Most commodities were in the red on Thursday as the market took a breather from ongoing rallies in precious…
Silver’s importance as an industrial metal and the tight supply situation present a positive backdrop for prices.However, risks from…
Europe enters the week with a mix of economic resilience and geopolitical strain.Britain’s stronger-than-expected growth has lifted market confidence,…
Global markets and politics are colliding as power, technology, and capital flow come under renewed strain.In the United States,…
Three US House Democrats are accusing the Securities and Exchange Commission of stepping back from its enforcement role in…